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Cognition-Enhancing Properties of Subchronic
Phosphatidylserine (PS) Treatment in
Middle-Aged Rats: Comparison of Bovine
Cortex PS With Egg PS and Soybean PS
ARJAN BLOKLAND, PHD,* WIEL HONIG,† FRED BROUNS, PHD,‡ AND JELLE JOLLES, PHD†
From the *Faculty of Psychology and †Department of Psychiatry and Neuropsychology, Brain & Behavior
Institute, and the ‡Novartis Nutrition Research Unit, Maastricht University, Maastricht, The Netherlands
ABSTRACT
There are various clinical and non-clinical studies that have indicated that phosphatidylserine (PS) treatment can improve
cognitive functions in humans and other animals. However, treatment with PS derived from bovine cortex is not desirable
because of possible transfer of infectious diseases. The present study investigated the cognition-enhancing properties of different
types of PS in rats. Seventeen-month-old male Fischer 344 rats were treated daily with a dose of 15 mg/kg of PS derived from
bovine cortex (BC-PS), soybean (S-PS), egg (E-PS), or vehicle (n 5 9 for each group). The effects of treatment were evaluated
in three different behavioral tests. An open field test was conducted to examine the effects of treatment on psychomotor behavior.
Two other tests (Morris water escape task and two-way active avoidance) assessed treatment effects on the cognitive performance
of rats. Treatment with the different forms of PS did not affect the psychomotor or spatial discrimination performance of the rats.
In accordance with previous studies, the cognition-enhancing effects of BC-PS were observed in the two-way active avoidance
task. It appeared that the cognition-enhancing effects of S-PS were not different from those of BC-PS. The performance of rats
treated with E-PS did not deviate from that of vehicle-treated rats. On the basis of the present study, it was concluded that S-PS,
but not E-PS, may have comparable effects on cognition when compared with BC-PS. Nutrition 1999;15:778–783. ©Elsevier
Science Inc. 1999
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INTRODUCTION
Phosphatidylserine (PS) is a naturally occurring phospholipid,
and it plays an important role in the functioning of the membrane
in neurons, e.g., maintenance of the cell’s internal environment,
signal transduction, secretory vesicle release, cell-to-cell commu-
nication, and cell growth regulation.1–5 Thus, it may not be sur-
prising that this phospholipid is considered to be an important
brain cell nutrient.
Aging is mostly associated with a deterioration in cognitive
functions. This age-related impairment in cognitive functions is
strongly related to a decrease in neurotransmitter6,7 and neuro-
nal8,9 functions. Thus, treatment with PS, known to be structurally
and functionally significant to brain cells, may attenuate the age-
related loss of neuronal functions and thus improve cognitive
functions.
It has been found that treatment with PS enhances cholinergic
neurotransmission10,11 and also appears to increase the turnover of
dopamine and norepinephrine in the brain.3 Another study has
reported that brain sections preincubated with PS produce an in-
crease in [3H]dl-a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic
acid binding when compared with brain sections under control
conditions.12 These data indicate that PS has an effect on neuro-
transmitters that may play a role in cognitive functions. Clinical
studies have provided some evidence that PS can improve cogni-
tive functions in demented patients,13,14 providing further evi-
dence that the central effects of PS treatment have beneficial
effects on cognitive functions (for review, see Pepeu15).
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PS can be obtained from several sources. Bovine cortex PS
(BC-PS) has been used to study the cognition-enhancing proper-
ties in rodents, but the use of BC-PS in humans is problematic
because of possible transfer of infectious diseases (e.g., bovine
spongiform encephalopathy). Another constraint against using
BC-PS is that the yield of PS from bovine cortex is rather low.
Alternative sources for PS are soybean (S-PS) and egg (E-PS). PS
from these sources has a similar molecular makeup with respect to
glycerol moiety and serine head group, but the fatty acid compo-
sition is different. S-PS is virtually devoid of arachidonic and
docosa hexenoic acid, whereas BC-PS and E-PS are identically
rich with these fatty acids.
The aim of the present study was to examine whether E-PS and
S-PS had behavioral properties similar to those of BC-PS in the
laboratory rat. Middle-aged rats, which usually show a modest
natural decline in cognitive performance, were tested in three
different tests. The first test was the open field test (OF), which is
assumed to test the emotional state of rats16 but can also be
regarded as a test for the psychomotor behavior of rats.17 The
second test was the Morris water escape task (MWET), a test that
assesses the spatial discrimination ability of rats.18 The last test
was the two-way active avoidance test (TWAA), which was used
to compare the results of the present experiment with those of
previous studies with PS treatment.19
MATERIALS AND METHODS
Animals
Thirty-six 12-mo-old Fischer 344 rats (F344/NHsd) were pro-
vided by Harlan Sprague-Dawley, Inc. (Houston, TX, USA). Five
months after arrival in our laboratory, the rats were matched by
body weight and placed into one of four different groups: vehicle,
BC-PS, S-PS, and E-PS (n 5 9 per group). At the start of the
behavioral experiments, the rats were 17 months old.
Treatment
E-PS and S-PS were supplied by Lucas Meyer (Decatur, IL,
USA). BC-PS was obtained from Avanti Polar Lipids (Alabaster,
AL, USA). All solutions and the vehicle (0.75% Epikuron 110, a
deoiled soybean lecithin, and 0.2% ethylene-diaminetetraacetic
acid B; Lageron) were prepared by Lucas Meyer.
The rats were injected (intraperitoneally in a volume of 2
mL/kg) daily with one of the treatments. The dose of each PS
treatment was 15 mg/kg, which was based on the behavioral active
dose of BC-PS reported in previous studies.19,20 The rats were
injected with the substance between 0800 and 0830 h and testing
started at least 1 h after injection. Treatment started 4 days before
the first (OF) test was conducted and was continued until behav-
ioral testing was completed.
Behavioral Tests
Open field test. OF behavior was assessed in a square base
(100 3 100 cm) divided into 36 equal squares by black lines. Two
red fluorescent strip lights provided very dim illumination (ap-
proximately 3 lx) on the floor of the apparatus.
Immediately after a rat was placed in the center of the OF, its
movements were scored. The total number of line crossings and
the total time spent in the corner, wall, and center squares were
recorded manually with an MS-DOS–compatible computer. Test-
ing was done over 3 consecutive days in 5-min daily sessions.
Morris water escape task. Performance in the MWET was
assessed in a water tank that consisted of a circular black tub, with
a slightly sloping wall (polyethylene; inner dimensions: diameter
at top 5 153 cm, diameter at bottom 5 143 cm, depth 5 63 cm),
filled with 43.5 cm of clear tap water at a temperature of approx-
imately 22°C. The escape platform consisted of a black polyeth-
ylene cylinder (diameter 5 10.8 cm) submerged 1.5 cm below the
surface of the water. In this version, the water was not made
opaque because a black escape platform is invisible in a black
tank.
The water tank was situated in a room illuminated by white
fluorescent strip lights. Abundant extra-maze cues were provided
by the furniture in the room, including desks, computer equip-
ment, a second water tank, the presence of the experimenter, and
a radio on a shelf that was playing softly. All testing was done
between 0900 and 1500 h.
A video camera, mounted in the center above the circular pool,
provided a picture of the pool on a television monitor. The
movements of a rat were automatically registered with a computer
program (EthoVision, Noldus equipment, Wageningen, The Neth-
erlands) and stored in an MS-DOS–compatible computer.
The animals received four trials during five acquisition ses-
sions that were held on 5 consecutive days. A trial was started by
placing a rat in the pool, facing the wall of the tank. Each of four
starting positions (north, east, south, and west) was used once in
a series of four trials; order was randomized. The escape platform
was always in the same quadrant. A trial was terminated as soon
as the rat had climbed onto the escape platform or when 60 s had
elapsed, whichever event occurred first. After about 3 s, the rat
was taken from the platform and put in a cage. After about 10 min,
the next trial was started. Rats that did not find the platform within
60 s were put on the platform by the experimenter for about 3 s
and then removed from the platform. After completion of the
fourth trial (on the 5th d after completion of the probe trial; see
below), the rat was returned to its home cage.
A probe trial was given after the fourth trial of the fifth daily
session. In this additional trial, the platform was removed, and the
time a rat spent in the four quadrants was measured for 30 s. In the
probe trial, all rats started from the same position, opposite the
quadrant where the escape platform had been positioned during
acquisition.
Two-way active avoidance. Acquisition and retention of the
TWAA task were assessed simultaneously in two shuttleboxes
interfaced to an MS-DOS–compatible computer that controlled
the trials and collected the data.
A rat was placed into the shuttlebox. The unconditioned stim-
ulus (UCS; a 0.28-mA scrambled foot shock) started 10 s after the
onset of the conditioned stimulus (CS; a tone and a light) if the rat
had not made an avoidance response by moving to the other
compartment during CS presentation. Both the UCS and the CS
were terminated when the rat escaped to the other compartment or
when 10 s had elapsed, whichever event occurred first. Retention/
second acquisition was assessed 24 h after the first acquisition
session.
The conditioning trials were separated by intertrial intervals of
20–60 s (average 5 40 s). During this interval, the number of
intertrial crossings was counted. The animals received 50 trials
during both the acquisition and the retention/second acquisition
sessions. The avoidance responses, i.e., moving to the other com-
partment of the test apparatus after presentation of the CS but
before the shock was delivered, and the escape responses, i.e.,
moving to the other side during presentation of the foot shock,
were recorded automatically. In addition, intertrial crossings, i.e.,
moving to the other side in the absence of UCS and CS, were
registered.
Statistical Analysis
Open field test. The data of the OF test were aggregated over
the 3 d to enhance reliability. Four aggregated variables are
reported:
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c mean time spent in the corner, wall, and center squares of the
OF
c mean frequency of entering the compartments and crossing
segments (i.e., of line crossings); this variable was used as a
measure of horizontally directed motor activity
c mean frequency of rearing and leaning in the entire appara-
tus; this variable was used as a measure of vertically directed
motor activity
c mean frequency of grooming bouts.
The mean time (in tenths of seconds) spent in the corner squares
was transformed logarithmically (Ln[{t1 1 t2 1 t3}/3], where t1–3
refers to days 1–3 of testing) to remove inhomogeneity. A one-
way analysis of variance (ANOVA) was used to test treatment
effects on the different variables. The Student–Newman–Keuls
post hoc test completed the statistical analysis (critical alpha
value 5 0.05). Two rats in the BC-PS treatment group did not
show any activity during the 3 d. A Dixon extremity test indicated
that these rats could be excluded from the statistical analysis.
Morris water escape task. For the analysis of the MWET data,
the totals of four trials were calculated (performance per day).
Three different parameters of spatial discrimination acquisition
performance were analyzed: total distance swum to reach the
platform, total latency to reach the platform, and average swim-
ming speed.
To quantify the search behavior of rats during the probe trials,
two different measures were analyzed: total time spent in the
target quadrant and total time spent in the platform region.
The data of the acquisition were analyzed using a two-factorial
design (treatment and blocks) with a repeated measures factor of
blocks. A one-way ANOVA was used to test treatment effects in
the probe trial. The Student–Newman–Keuls post hoc analysis
evaluated the data in more detail (critical alpha value 5 0.05).
Two-way active avoidance. The mean numbers of avoidances,
escape responses, and intertrial crossings were calculated per
block of 10 trials. Also, the number of barrier crossings during the
adaptation phase was measured. It appeared that the data of the
parameter avoidances were not normally distributed and, as a
consequence, were transformed to rank scores (except for the
analysis of the improvement of avoidance behavior, where the raw
data were used). The data were analyzed with a two-factorial
ANOVA (treatment and blocks) with blocks as a repeated mea-
sures factor. Post hoc analyses on the linear trend components
evaluated the differences between treatment groups in more detail
(Student–Newman–Keuls, critical a-value 5 0.05).
RESULTS
Open Field Test
The time the rats spent in the different areas was not affected
by treatment with the different types of PS (all associated proba-
bilities of ANOVAs: P . 0.10; Fig. 1A). As shown in Figure 1B,
treatment with different sources of PS did not affect the activity of
the rats in the OF test (all associated probabilities of ANOVAs:
P . 0.10). The results of rearing and grooming behavior are not
shown because no treatment effects were found (all associated
probabilities of ANOVAs: P . 0.10).
Morris Water Escape Task
Figure 2 shows the data of the different parameters of MWET
behavior. All rats readily learned the task (distance: block effect
FIG. 1. Open field behavior: Data are aggregated means (6SEM) of three sessions that were done on 3 consecutive days for groups of rats treated with
phosphatidylserine (PS) obtained from different sources. PS treatment did not affect the time the rats spent in the different areas (A) or the behavioral
activity of the rats in the open field (B).
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F[4,128] 5 54.27, P , 0.01, Fig. 2A; latency: block effect
F[4,128] 5 75.36, P , 0.01, Fig. 2B). The rats spent half the
probe trial in the quadrant in which the platform was located
during the training of the task, indicating that they had learned the
spatial location of the platform (Fig. 2D–E). However, PS treat-
ment did not affect the performance of the rats on any of the
measures of spatial discrimination performance (all associated
probabilities of ANOVAs: P . 0.10). Although the swimming
speed seemed to be higher in the different treatment groups when
compared with the vehicle group (Fig. 2C), this was not confirmed
statistically (treatment and treatment 3 block: Fs , 1.59, NS).
Two-Way Active Avoidance
The rats learned to avoid the foot shock during the session with
50 trials (blocks: F[4,128] 5 14.33, P , 0.01, Fig. 3A). In the
TWAA test, a treatment effect was found for the number of
avoidances the rats made during the first acquisition session
(F[3,32] 5 3.43, P , 0.05). Post hoc analysis showed that the rats
treated with BC-PS and S-PS made more avoidances during the
session of 50 trials than did the vehicle-treated rats. The perfor-
mance of the rats treated with E-PS did not deviate from that of the
rats in the other groups. During the second acquisition session,
another performance improvement was observed (blocks:
F[4,128] 5 21.13, P , 0.01). There was a tendency of treatment
effect for the number of avoidances made by the rats (F[3,32] 5
2.83, P , 0.06, Fig. 3A). Post hoc analysis on the general mean
indicated that the BC-PS–treated rats made more avoidances than
did the vehicle-treated rats. The performance of rats treated with
S-PS or E-PS did not differ from that of rats in the other treatment
groups.
There was also an indication that treatment with PS affected
the number of escapes during the first acquisition session (treat-
FIG. 2. Performance of rats treated with different types of phosphatidylserine (PS) in the spatial Morris maze task: (A) distance swum to find the platform,
(B) time needed to find the platform, (C) swimming speed, (D) time spent in the target quadrant during the probe trial, and (E) time spent in the platform
area during the probe trial. Treatment with PS did not affect the performance of the rats on any measure. TQ, target quadrant.
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ment 3 blocks: F[12,128] 5 2.46, P , 0.01, Fig. 3A). This
interaction effect was difficult to interpret but was most likely
related to the fluctuations in the behavior of the vehicle-treated
rats. Although the BC-PS group seemed to show more escape
responses than the vehicle-treated group during the second acqui-
sition (Fig. 3B), this was not confirmed statistically (treatment:
F[3,32] 5 0.16, NS). However, a treatment 3 blocks effect was
found (F[12,128] 5 1.89, P , 0.05), suggesting that the decrease
in escape responses was different for the treatment groups. There
were no treatment effects on the measure intertrial crossings (all
associated probabilities of ANOVAs: P . 0.10).
Body Weight
During the course of treatment, the body weights of the rats
decreased (weeks: F[4,128] 5 352.93, P , 0.01) and diverged for
the groups treated with different types of PS (weeks 3 treatment:
F[12,128] 5 5.33, P , 0.01, Fig. 4). This difference was due to
the lower body weights of the E-PS–treated rats during the course
of testing. During week 5, the rats treated with E-PS weighed less
than the rats in the other treatment groups (F[3,32] 5 6.54, P ,
0.01).
DISCUSSION
The present study has examined the effects of treatment with
different types of PS on behavior in middle-aged rats. Based on
previous reports on the effects of BC-PS in rats in avoidance
tasks,19 all substances were given in a dose of 15 mg/kg intraperi-
toneally. Based on the comparable molecular makeup of the
substances, it was assumed that E-PS and S-PS would have a
bioavailability similar to that of BC-PS.
In the OF and MWET tests, no effects of PS treatment were
observed. The lack of effect of PS on behavioral activity in the OF
test corroborates findings from a previous study.21 The OF test has
been found to be a very sensitive test for pharmacologic treat-
ments.22 However, no change in behavior in the OF test can also
imply that the treatments had no negative side effects.17 Because
no effects were found in this test, it was concluded that PS
treatment did not affect behavioral activity or emotional reactivity
in rats. In addition, it could be concluded that PS treatment does
not have adverse effects on the physiologic state of the rats.
There are only a few substances that have been shown to
improve the performance of old rats in the MWET. The MWET is
assumed to be a task with a high face validity for testing
cognition-enhancing compounds. It can be argued that the limited
number of substances that can improve MWET performance re-
flects the present status of cognition enhancers. At present, tacrine
(Cognex, Boston, MA, USA) is the only approved medication for
the treatment of the cognitive dysfunctions in Alzheimer’s disease.
However, it has been shown that tacrine has no beneficial effects
in the MWET task in middle-aged rats,23 but it has been shown to
be effective in other animal models of dementia.24 However, no
direct comparison can be made between the effects of tacrine and
PS until these drugs are tested in the same study.
FIG. 4. Body weight of the rats treated with different types of phospha-
tidylserine (PS). During the experiments, the body weights of the rats
treated with egg PS decreased faster than did the body weights of rats
treated with bovine cortex PS, soybean PS, or vehicle.
FIG. 3. Performance of rats treated with different types of phosphatidyl-
serine (PS) in the two-way active avoidance task: (A) avoidance responses
and (B) escape responses. Treatment with bovine cortex PS and soybean
PS improved the avoidance performance when compared with vehicle
treatment. AC1, adaptation crossings during first adaptation phase; AC2,
adaptation crossings during second adaptation phase.
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The improved performance of rats treated with BC-PS in the
TWAA test corroborates previous findings in a similar
task.19,21,25,26 Therefore, avoidance tasks (i.e., active avoidance
and passive avoidance) can be considered a sensitive test for PS
treatment. S-PS treatment had similar effects when compared with
BC-PS treatment, i.e., the performance of this group was better
than that of the vehicle-treated group. A previous study also found
ameliorating effects of BC-PS and S-PS in a scopolamine-induced
memory deficit as assessed by an avoidance task.25 The perfor-
mance of the group treated with E-PS did not differ from that of
the vehicle group on any measure. Although there was no statis-
tical reliable difference between the E-PS and S-PS groups, the
mean performance of the rats treated with S-PS was higher than
that of the E-PS–treated rats.
The reason E-PS produced inactivity whereas S-PS produced
activity in the TWAA test is not clear. Because the fatty acid
composition of E-PS (which is relatively high in arachidonic acid
and docosa hexenoic acid) versus that of S-PS more closely
matches the composition of brain phospholipids, which is high in
linoleic acid, we were surprised by this observation. Thus, we can
only speculate that the E-PS may have lost bioactivity because of
a breakdown of the bioactive compound during processing or
storage.
Other studies with PS treatment have used higher doses of
BC-PS and S-PS. For example, in a recent study by Sakai et al.,25
S-PS or BC-PS was given in a dose of 60 mg/kg (intraperitone-
ally). However, in that study, the acute effects of a single PS
injection were investigated. In another study, PS was given for 12
weeks in a dose of 50 mg/kg/d to aged, impaired rats.26 In both
studies, PS treatment improved the performance of the rats. Drago
et al.19 tested the effects of PS in a dose range of 5–20 mg/kg
intraperitoneally, and they found cognition-enhancing effects of
PS. Also, other studies have indicated that a dose of 15 mg/kg
exerts effects on the brain.2,4,10,11 These data imply that high doses
of PS can be applied to obtain a beneficial effect. Apparently,
there is a wide therapeutic window for PS treatment.
A final point for discussion is related to the effects of PS
treatment on body weight. The decline in body weight in rats
subjected to behavioral tests is normal. The physical effort of the
rats made in the different tests and the mild stress the rats expe-
rienced are assumed to lead to a decrease in the freely feeding
body weight. PS has been reported to act protectively against
stress-induced behavioral and autonomic changes.20 However, this
cannot explain the lack of difference between the vehicle and
BC-PS groups and does not account for the observation that
E-PS–treated rats reduced their weight more rapidly than did the
rats in the other treatment (including vehicle) groups.
In summary, the present study has shown that BC-PS improved
the performance of middle-aged rats in a TWAA task. S-PS, but
not E-PS, appeared to have effects similar to those of BC-PS.
However, another cognitive task did not show any beneficial effect
of PS treatment. PS treatment did not affect the psychomotor
performance of rats as assessed in an OF test. On the basis of the
present data, it was concluded that S-PS may be regarded as a
possible alternative to BC-PS for treating cognitive dysfunctions.
SUMMARY
The cognition-enhancing properties of subchronic treatment
with different types of PS were investigated in middle-aged rats.
It was found that treatment with S-PS, but not E-PS, had positive
effects similar to those of BC-PS in an avoidance task.
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